Risk Factors and Prognosis of Carbapenem-Resistant Klebsiella pneumoniae Infections in Respiratory Intensive Care Unit: A Retrospective Study

References

• ReyesJ, AguilarAC, CaicedoA. Carbapenem-resistant klebsiella pneumoniae: microbiology key points for clinical practice. Int J Gen Med. 2019;12(2):437–446. doi:10.2147/IJGM.S21430531819594
   PubMed Web of Science ®Google Scholar
• Navon-VeneziaS, KondratyevaK, CarattoliA. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):252–275. doi:10.1093/femsre/fux01328521338
   PubMed Web of Science ®Google Scholar
• BrinkAJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 2019;32(6):609–616. doi:10.1097/QCO.000000000000060831567571
   PubMed Web of Science ®Google Scholar
• ZhangR, LiuL, ZhouH, et al. Nationwide surveillance of clinical carbapenem-resistant enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98–106. doi:10.1016/j.ebiom.2017.04.03228479289
   PubMed Web of Science ®Google Scholar
• XuL, SunX, MaX. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-328356109
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States [EB/OL]. USA: Centers for Disease Control and Prevention; 1113, 2019 [June 08, 2021]. Available from:https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Accessed 811, 2021.
   Google Scholar
• Suay-GarciaB, Perez-GraciaMT. Present and future of carbapenem-resistant enterobacteriaceae (CRE) Infections. Antibiotics (Basel). 2019;8(3):122.
   PubMed Web of Science ®Google Scholar
• ZhangG, ZhangM, SunF, et al. Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing. J Infect Public Health. 2020;13(11):1710–1714. doi:10.1016/j.jiph.2020.09.01233082112
   PubMed Web of Science ®Google Scholar
• LiuB, YiH, FangJ, et al. Antimicrobial resistance and risk factors for mortality of pneumonia caused by Klebsiella pneumoniae among diabetics: a retrospective study conducted in Shanghai, China. Infect Drug Resist. 2019;12(2):1089–1098. doi:10.2147/IDR.S19964231123410
   PubMed Web of Science ®Google Scholar
• YangXD, ZhaoYS, LiYF, et al. Medical comorbidities at admission is predictive for 30-day in-hospital mortality in patients with acute myocardial infarction: analysis of 5161 cases. J Geriatr Cardiol. 2011;8(1):31–34. doi:10.3724/SP.J.1263.2011.0003122783282
   PubMedGoogle Scholar
• FakhrySM, LeonS, DerderianC, et al. Intensive care unit bounce back in trauma patients: an analysis of unplanned returns to the intensive care unit. J Trauma Acute Care Surg. 2013;74(6):1528–1533. doi:10.1097/TA.0b013e31829247e723694883
   PubMed Web of Science ®Google Scholar
• SullivanMC, RomanSA, SosaJA. Clinical and economic outcomes of thyroid surgery in elderly patients: a systematic review. J Thyroid Res. 2012;2012:615846. doi:10.1155/2012/61584622779035
   PubMedGoogle Scholar
• ZhengC, CaiJ, LiuH, et al. Clinical characteristics and risk factors in mixed-enterococcal bloodstream infections. Infect Drug Resist. 2019;12:3397–3407. doi:10.2147/IDR.S21790531802919
   PubMed Web of Science ®Google Scholar
• ZuoY, ZhaoD, SongG, et al. Risk factors, molecular epidemiology, and outcomes of carbapenem-resistant klebsiella pneumoniae infection for hospital-acquired pneumonia: a matched case-control study in Eastern China during 2015–2017. Microb Drug Resist. 2021;27(2):204–211. doi:10.1089/mdr.2020.016232614722
   PubMed Web of Science ®Google Scholar
• YuanY, WangJ, YaoZ, et al. Risk factors for carbapenem-resistant klebsiella pneumoniae bloodstream infections and outcomes. Infect Drug Resist. 2020;13:207–215. doi:10.2147/IDR.S22324332158236
   PubMed Web of Science ®Google Scholar
• HeG, HuangJ, HuangS, et al. Risk factors affecting clinical outcome in patients with carbapenem-resistant K. pneumoniae: a retrospective study. Med Sci Monit. 2020;26:e925693. doi:10.12659/MSM.92569333098640
   PubMed Web of Science ®Google Scholar
• ChangH, WeiJ, ZhouW, et al. Risk factors and mortality for patients with bloodstream infections of Klebsiella pneumoniae during 2014–2018: clinical impact of carbapenem resistance in a large tertiary hospital of China. J Infect Public Health. 2020;13(5):784–790. doi:10.1016/j.jiph.2019.11.01431843651
   PubMed Web of Science ®Google Scholar
• WangZ, QinRR, HuangL, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae infection. Chin Med J (Engl). 2018;131(1):56–62. doi:10.4103/0366-6999.22126729271381
   PubMed Web of Science ®Google Scholar
• GirijanSK, PaulR, VjJR, et al. Investigating the impact of hospital antibiotic usage on aquatic environment and aquaculture systems: a molecular study of quinolone resistance in Escherichia coli. Sci Total Environ. 2020;748:141538. doi:10.1016/j.scitotenv.2020.14153832805571
   PubMed Web of Science ®Google Scholar
• ZhuWM, YuanZ, ZhouHY. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):23. doi:10.1186/s13756-020-0686-032005246
   PubMed Web of Science ®Google Scholar
• GeladariA, SimitsopoulouM, AntachopoulosC, et al. Immunomodulatory effects of colistin on host responses against carbapenem-resistant Klebsiella pneumoniae biofilms. Int J Antimicrob Agents. 2020;56(6):106182. doi:10.1016/j.ijantimicag.2020.10618233045355
   PubMed Web of Science ®Google Scholar
• FangL, XuH, RenX, et al. Epidemiology and risk factors for carbapenem-resistant Klebsiella pneumoniae and subsequent MALDI-TOF MS as a tool to cluster KPC-2-producing Klebsiella Pneumoniae, a retrospective study. Front Cell Infect Microbiol. 2020;10:462. doi:10.3389/fcimb.2020.0046233042858
   PubMed Web of Science ®Google Scholar
• TammaPD, GoodmanKE, HarrisAD, et al. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant enterobacteriaceae bacteremia. Clin Infect Dis. 2017;64(3):257–264. doi:10.1093/cid/ciw74128013264
   PubMed Web of Science ®Google Scholar